McCone, J., Hu, K.-Q., McHutchison, J. G., Shiffman, M. L., King, J. W., Herrine, S. K., … Muir, A. J. (2008). SUSTAINED VIROLOGIC RESPONSE (SVR) AND PREDICTORS OF RESPONSE IN AFRICAN AMERICAN (AA) PATIENTS IN THE IDEAL (INDIVIDUALIZED DOSING EFFICACY VERSUS FLAT DOSING TO ASSESS OPTIMAL PEGYLATED INTERFERON THERAPY) PHASE 3B STUDY. In HEPATOLOGY (Vol. 48, pp. 430A-431A). San Francisco, CA: JOHN WILEY & SONS INC.

McCone, Jonathan, Ke-Qin Hu, John G. McHutchison, Mitchell L. Shiffman, John W. King, Steven K. Herrine, Greg Wayne Goller, et al. “SUSTAINED VIROLOGIC RESPONSE (SVR) AND PREDICTORS OF RESPONSE IN AFRICAN AMERICAN (AA) PATIENTS IN THE IDEAL (INDIVIDUALIZED DOSING EFFICACY VERSUS FLAT DOSING TO ASSESS OPTIMAL PEGYLATED INTERFERON THERAPY) PHASE 3B STUDY.” In HEPATOLOGY, 48:430A-431A. JOHN WILEY & SONS INC, 2008.

McCone J, Hu K-Q, McHutchison JG, Shiffman ML, King JW, Herrine SK, et al. SUSTAINED VIROLOGIC RESPONSE (SVR) AND PREDICTORS OF RESPONSE IN AFRICAN AMERICAN (AA) PATIENTS IN THE IDEAL (INDIVIDUALIZED DOSING EFFICACY VERSUS FLAT DOSING TO ASSESS OPTIMAL PEGYLATED INTERFERON THERAPY) PHASE 3B STUDY. In: HEPATOLOGY. JOHN WILEY & SONS INC; 2008. p. 430A-431A.

McCone, Jonathan, et al. “SUSTAINED VIROLOGIC RESPONSE (SVR) AND PREDICTORS OF RESPONSE IN AFRICAN AMERICAN (AA) PATIENTS IN THE IDEAL (INDIVIDUALIZED DOSING EFFICACY VERSUS FLAT DOSING TO ASSESS OPTIMAL PEGYLATED INTERFERON THERAPY) PHASE 3B STUDY.” HEPATOLOGY, vol. 48, no. 4, JOHN WILEY & SONS INC, 2008, pp. 430A-431A.

McCone J, Hu K-Q, McHutchison JG, Shiffman ML, King JW, Herrine SK, Goller GW, Sulkowski M, Nunes F, Brown KAA, Gordon SC, Mullen KD, Ravendhran N, Cassidy WM, Ghalib RH, Deng W, Noviello S, Albrecht JK, Muir AJ. SUSTAINED VIROLOGIC RESPONSE (SVR) AND PREDICTORS OF RESPONSE IN AFRICAN AMERICAN (AA) PATIENTS IN THE IDEAL (INDIVIDUALIZED DOSING EFFICACY VERSUS FLAT DOSING TO ASSESS OPTIMAL PEGYLATED INTERFERON THERAPY) PHASE 3B STUDY. HEPATOLOGY. JOHN WILEY & SONS INC; 2008. p. 430A-431A.